Skip to main content

Table 1 Clinical characteristics for the patients

From: Fast-acting treatment of myasthenic crisis with efgartigimod from the perspective of the neonatal intensive care unit

 

Age at diagnosis

Sex

MG duration

Abs

Pathology of thymus

Thymectomy

Underlying disease

Skeletal muscle weakness of MG

Triggers for MC

The times of MC onset

Treatment before MC

Case 1

49

Female

5 months

Ach-R-Ab、Titin-Ab、RyR-Ab

Thymoma

  

Bulbar, respiratory and limb muscles

No obvious precipitant

1

CS 8 mg, Pyd 60 mg t.i.d, IVMP, IVIG

Case 2

42

Female

14 years

Ach-R-Ab、Titin-Ab

Thymoma

 

HTN

Ocular, bulbar, respiratory and limb muscles

Upper respiratory infection

1

CS 8 mg, Pyd 60 mg t.i.d, MMF 250 mg b.i.d, IVMP, IVIG

Case 3

32

Male

2 years

Ach-R-Ab、Titin-Ab

Thymoma

Yes

 

Ocular, respiratory and limb muscles

Aspiration pneumonia

1

CS 20 mg, Pyd 60 mg t.i.d, tac 2 mg, IVMP, IVIG

Case 4

27

Female

3 years

Ach-R-Ab、Titin-Ab

Thymic hyperplasia

Yes

 

Ocular, bulbar, neck, respiratory and limb muscles

No obvious precipitant

2

CS 20 mg, Pyd 60 mg q6h, tac 3 mg, IVMP, IVIG

Case 5

69

Female

1 year

Musk-Ab

Normal

 

PE、PMV、Tr

Bulbar, respiratory and limb muscles

Aspiration pneumonia

1

No

  1. MG = myasthenia gravis; Ach-R-Ab = acetylcholine receptor antibodies; Titin-Ab = Titin antibodies; Musk-Ab = muscle-specific tyrosine kinase antibodies; RyR-Ab = Ryanodine receptor antibodies; HTN = hypertension; PE = pulmonary embolism; PMV = prolapse of mitral valve; TR = tricuspid regurgitation; CS = prednisone/methylprednisolone; Pyd = pyridostigmine; MMF = mycophenolate mofetil; Tac = tacrolimus